Clinical Trials Logo

Filter by:
NCT ID: NCT01553604 Completed - Clinical trials for Surgical Site Infection

Dressing Wear Time After Breast Augmentation With Prosthesis

Start date: July 2013
Phase: N/A
Study type: Interventional

This study was designed to determine whether the duration of dressing wear following augmentation mammaplasty influence skin colonization and eventually surgical site infections rates.

NCT ID: NCT01551277 Completed - Morbidly Obese Clinical Trials

Use of Breath Stacking Technique on Regional Ventilation in Box Chest in Women With Morbid Obesity

Start date: March 2010
Phase: N/A
Study type: Interventional

Objectives: To evaluate the effects of the technique of Breath Stacking (BS) in the distribution of ventilation in the chest in women with morbid obesity. Methods: Randomized clinical trial, blinded, and controlled with 32 women (BMI ≥ 40kg/m2), separated into two groups: control (GC) with n = 16 and 41.94 ± 9.38 years and group Breath Stacking (GBS) , n = 16 and 40.38 ± 10.16 years. Optoelectronic plethysmography (POE) was used to assess lung ventilation. For the BS technique was used to mask the expiratory branch occluded and Wright spirometer. GBS held three techniques with an interval of three minutes. The GC used the same circuit without the occlusion of the expiratory branch. Results: GBS was found to be higher in the contribution of tidal volume (VT) into the chest circumference (p = 0.04) and decrease in abdominal compartment (p = 0.03), whereas the CG showed no difference in distribution. Spirometric variables: FEV1 (%), FVC (%), FEV1/FVC (%), VC and CI showed no difference before and after the technical BS and GBS in the GC. Conclusions: The technique BS altered the distribution pattern of regional ventilation, resulting in greater contribution in lung volume in the lower rib cage, corresponding to activity of the diaphragm, with redistribution of volume between compartments.

NCT ID: NCT01550887 Completed - Clinical trials for Substance Dependence

Evaluation of Impulsivity on Cocaine and Crack Addicts

Start date: April 2012
Phase: N/A
Study type: Interventional

This study main objective is investigating impulsivity on cocaine or crack addicts. The investigators main hypothesis is that different measures (such as scales or behavioral tasks, for example) of impulsivity may produce distinct outcomes, and they might also differ among cocaine (sniffed) and crack users. Thus, it would be of great value to compare such measures once these data are often interpreted as the same phenomenon.

NCT ID: NCT01550016 Completed - Dengue Fever Clinical Trials

International Research Consortium on Dengue Risk Assessment, Management, and Surveillance

IDAMS
Start date: October 2011
Phase: N/A
Study type: Observational

Improvements in diagnosis of dengue fever and prediction of which patients will get more severe disease are urgently needed to improve the treatment of patients with dengue. This is very important in places with many people who suffer from dengue but have limited health care resources. This study will enroll patients with fever which may be caused by dengue in 6 countries with high incidence of dengue over two continents (Brazil, Cambodia, El Salvador, Indonesia, Malaysia and Vietnam). All patients will be followed by a doctor with blood tests and exams until they recover. Symptoms and laboratory tests will be followed so that the cause of fever can be determined. For patients who have dengue, the investigators will look for symptoms and tests which indicate more serious disease. This study will help to determine how to identify patients with dengue fever based on symptoms and simple laboratory tests and those who will get more serious disease. It will also help to define a more standardized management of patients with dengue fever.

NCT ID: NCT01550003 Completed - Clinical trials for Polyarticular-course Juvenile Idiopathic Arthritis (JIA)

Pediatric Arthritis Study of Certolizumab Pegol

PASCAL
Start date: March 8, 2012
Phase: Phase 3
Study type: Interventional

A Multicenter, Open-label Study to Assess the Pharmacokinetics, Safety and Efficacy of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Polyarticular-course Juvenile Idiopathic Arthritis (JIA).

NCT ID: NCT01549626 Completed - Overweight Clinical Trials

Effects of Flaxseed Flour in Appetite Sensations, Lipid Profile and Pressure Levels Among Overweighed and Obese Women

Start date: March 2009
Phase: N/A
Study type: Interventional

Inclusion of foods rich in fiber, such as flaxseed, is a nutritional strategy for treating obesity. The hypothesis of this study is to compare the effects of three types of flaxseed flour - whole brown flaxseed flour, brown defatted flaxseed flour and golden flaxseed flour in the sensations of appetite and satiety, lipid profile, pressure levels and associated costs in overweight and obese women.

NCT ID: NCT01549301 Completed - Healthy Subjects Clinical Trials

Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indústria e Comércio Ltda. Compared to Granulokine Produced by Produtos Roche Químicos e Farmacêuticos S/A.

Start date: August 2012
Phase: Phase 1
Study type: Interventional

The primary aim of this study is to compare the pharmacokinetic and pharmacodynamic effects of two commercial preparations of filgrastim (T and C), after single dose via subcutaneous or intravenous administration at a concentration of 5 mcg/kg or 10 mcg/kg in healthy subjects through the alteration in the pharmacokinetic and pharmacodynamic parameters (measurement of serum levels of G-CSF and absolute neutrophil count - ANC).

NCT ID: NCT01548950 Completed - Clinical trials for Pulmonary Arterial Hypertension

Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension

Start date: September 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to test the hypothesis that treating PAH-CHD patients preoperatively with PAH drugs and keeping them on treatment for six months after surgery reduces the risk of immediate postoperative death and the risk of residual PAH at six months following operation to <10%.

NCT ID: NCT01548612 Completed - Schizophrenia Clinical Trials

Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia

Start date: February 2006
Phase: Phase 2
Study type: Interventional

In spite of the numerous studies on schizophrenia, its etiology and physiopathology remain unknown. Evidence suggests a possible implication of nitric oxide (NO) in schizophrenia. NO is a gas with unique chemistry and influences the release of neurotransmitters, learning, memory and neurodevelopment. Recent studies that investigated the role of NO in patients with schizophrenia found evidence that points to a disruption in NO-mediated neurotransmission in schizophrenia. Accordingly, we believe that the administration of sodium nitroprusside, an NO donor, will ameliorate schizophrenia symptoms.

NCT ID: NCT01547377 Completed - Clinical trials for Dietary Zinc Deficiency

Zinc and Selenium Supplementation in Atherosclerosis

Start date: January 2008
Phase: N/A
Study type: Interventional

The aim of this randomized double-blind study was to evaluate the effect of oral zinc and selenium supplementation on oxidative stress and inflammation biomarkers as well as the status of zinc and selenium in patients with atherosclerosis and angina stable treated with rosuvastatin. The hypotheses tested in this study were: Treatment with rosuvastatin impairs zinc and selenium status in patients with atherosclerosis and stable angina? Zinc and selenium supplementation, concomitantly with rosuvastatin, influences the antioxidant and anti-inflammatory as well as the status of minerals?